Search research articles
Contact Us
Filters
Showing results (241-250 of 358) with videos related to
Page
of 36
Sort By:
Schizophrenia Bulletin
|
January 29, 2020
Network Analysis Indicates That Avolition Is the Most Central Domain for the Successful Treatment of Negative Symptoms: Evidence From the Roluperidone Randomized Clinical Trial
Gregory P Strauss, Farnaz Zamani Esfahlani, Hiroki Sayama, et al.
Diabetes Care
|
April 1, 2008
Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation
John D Brunzell, Michael Davidson, Curt D Furberg, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
December 5, 2016
The association between premorbid cognitive ability and social functioning and suicide among young men: A historical-prospective cohort study
Mark Weiser, Daphna Fenchel, Nomi Werbeloff, et al.
Cardiovascular Drugs and Therapy
|
May 25, 2012
Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial
Michael Davidson, Robert S Rosenson, Kevin C Maki, et al.
BMC Psychiatry
|
March 11, 2021
Acute day units for mental health crises: a qualitative study of service user and staff views and experiences
Nicola Morant, Michael Davidson, Jane Wackett, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
June 26, 2019
Exposure to Antidepressant Medication and the Risk of Incident Dementia
Arad Kodesh, Sven Sandin, Abraham Reichenberg, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
July 18, 2024
Network intervention analysis indicates that roluperidone achieves its effect on negative symptoms of schizophrenia by targeting avolition
Sydney H James, Anthony O Ahmed, Philip D Harvey, et al.
Biological Psychiatry
|
September 11, 2007
Subtle cognitive dysfunction in nonaffected siblings of individuals affected by nonpsychotic disorders
Mark Weiser, Abraham Reichenberg, Efrat Kravitz, et al.
Biological Psychiatry
|
September 18, 2003
Self-reported drug abuse in male adolescents with behavioral disturbances, and follow-up for future schizophrenia
Mark Weiser, Abraham Reichenberg, Jonathan Rabinowitz, et al.
Innovations in Clinical Neuroscience
|
June 18, 2020
Do Patterns of Instability or Severity of Psychopathology During Screening Predict Relapse in Schizophrenic Outpatient Subjects with Moderate to Severe Negative Symptoms Assigned to Placebo?
David G Daniel, Alan Kott, Jay Saoud, et al.
Page
of 36
Search research articles
Search
Showing results (241-250 of 358) with videos related to
Sort By:
Page
of 36
Schizophrenia Bulletin
|
January 29, 2020
Network Analysis Indicates That Avolition Is the Most Central Domain for the Successful Treatment of Negative Symptoms: Evidence From the Roluperidone Randomized Clinical Trial
Gregory P Strauss, Farnaz Zamani Esfahlani, Hiroki Sayama, et al.
Diabetes Care
|
April 1, 2008
Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation
John D Brunzell, Michael Davidson, Curt D Furberg, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
December 5, 2016
The association between premorbid cognitive ability and social functioning and suicide among young men: A historical-prospective cohort study
Mark Weiser, Daphna Fenchel, Nomi Werbeloff, et al.
Cardiovascular Drugs and Therapy
|
May 25, 2012
Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial
Michael Davidson, Robert S Rosenson, Kevin C Maki, et al.
BMC Psychiatry
|
March 11, 2021
Acute day units for mental health crises: a qualitative study of service user and staff views and experiences
Nicola Morant, Michael Davidson, Jane Wackett, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
June 26, 2019
Exposure to Antidepressant Medication and the Risk of Incident Dementia
Arad Kodesh, Sven Sandin, Abraham Reichenberg, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
July 18, 2024
Network intervention analysis indicates that roluperidone achieves its effect on negative symptoms of schizophrenia by targeting avolition
Sydney H James, Anthony O Ahmed, Philip D Harvey, et al.
Biological Psychiatry
|
September 11, 2007
Subtle cognitive dysfunction in nonaffected siblings of individuals affected by nonpsychotic disorders
Mark Weiser, Abraham Reichenberg, Efrat Kravitz, et al.
Biological Psychiatry
|
September 18, 2003
Self-reported drug abuse in male adolescents with behavioral disturbances, and follow-up for future schizophrenia
Mark Weiser, Abraham Reichenberg, Jonathan Rabinowitz, et al.
Innovations in Clinical Neuroscience
|
June 18, 2020
Do Patterns of Instability or Severity of Psychopathology During Screening Predict Relapse in Schizophrenic Outpatient Subjects with Moderate to Severe Negative Symptoms Assigned to Placebo?
David G Daniel, Alan Kott, Jay Saoud, et al.
Page
of 36